News

• FDA accepts Dupixent® (dupilumab) for review in children with moderate-to-severe asthma
  07:00 - GlobeNewswire
•  
• Sprott Focus Trust, Inc. (Nasdaq-FUND) Declares First Quarter Common Stock Distribution of $0.1044 Per Share
  03/03/2021 / 23:00 - GlobeNewswire
•  
• W&T Offshore Announces Fourth Quarter and Full Year 2020 Results Including Year-End 2020 Proved Reserves and Provides 2021 Guidance
  03/03/2021 / 22:52 - GlobeNewswire
•  
• PMV Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Corporate Highlights
  03/03/2021 / 22:01 - GlobeNewswire
•  
• The Royal Merges Sustainability and Luxury
  03/03/2021 / 19:32 - GlobeNewswire
•  
• Schneider outlines ongoing commitment to a sustainable future
  03/03/2021 / 16:55 - GlobeNewswire
•  
• CRISPR Therapeutics to Participate in Upcoming Investor Conferences
  03/03/2021 / 14:00 - GlobeNewswire
•  
• Ekso Bionics Teams Up with Performance Contracting, Inc. for Innovative Testing Approach of EVO™ Technology
  03/03/2021 / 14:00 - GlobeNewswire
•  
• PTA-DD: Bayer Aktiengesellschaft: Managers' transactions announcement according to article 19 MAR
  03/03/2021 / 10:00 - pressetext
•  
• PTA-DD: Bayer Aktiengesellschaft: Managers' transactions announcement according to article 19 MAR
  03/03/2021 / 10:00 - pressetext
•  
• PTA-DD: Bayer Aktiengesellschaft: Managers' transactions announcement according to article 19 MAR
  03/03/2021 / 10:00 - pressetext
•  
• PTA-DD: Bayer Aktiengesellschaft: Managers' transactions announcement according to article 19 MAR
  03/03/2021 / 10:00 - pressetext
•  
• PTA-DD: Bayer Aktiengesellschaft: Managers' transactions announcement according to article 19 MAR
  03/03/2021 / 10:00 - pressetext
•  
• PTA-DD: Bayer Aktiengesellschaft: Managers' transactions announcement according to article 19 MAR
  03/03/2021 / 10:00 - pressetext
•  
• PTA-DD: Bayer Aktiengesellschaft: Managers' transactions announcement according to article 19 MAR
  03/03/2021 / 10:00 - pressetext